October 21, 2008 — Clinicians should receive specialized training for the transvaginal placement of mesh products and be vigilant for adverse events, the US Food and Drug Administration (FDA) warned ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback